Endotyping of Cholesteatoma: Which Molecular Biomarkers? A Systematic Review.

These results are interesting especially from a prognostic point of view, nevertheless more studies are needed to search new biomarkers of C that could completely change not only the therapeutic standards of the disease, but also the clinical history of C itself in the era of precision medicine.